Denosumab as a promising novel bone-targeted agent in castration resistant prostate cancer.
Dellis A, Papatsoris AG.
Dellis A, et al. Among authors: papatsoris ag.
Expert Opin Biol Ther. 2014 Jan;14(1):7-10. doi: 10.1517/14712598.2013.840582. Epub 2013 Sep 27.
Expert Opin Biol Ther. 2014.
PMID: 24074253
Soc Clin Oncol Educ Book 2013;2013:161-5; Papatsoris AG, Karamouzis MV, Papavassiliou AG. Novel biological agents for the treatment of hormone-refractory prostate cancer (HRPC). ...
Soc Clin Oncol Educ Book 2013;2013:161-5; Papatsoris AG, Karamouzis MV, Papavassiliou AG. Novel biological agents for t …